{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:32:10Z","timestamp":1790857930388,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,3,15]],"date-time":"2005-03-15T00:00:00Z","timestamp":1110844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00213-005-2188-4","type":"journal-article","created":{"date-parts":[[2005,3,14]],"date-time":"2005-03-14T13:19:04Z","timestamp":1110806344000},"page":"501-512","source":"Crossref","is-referenced-by-count":48,"title":["Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization"],"prefix":"10.1007","volume":"180","author":[{"given":"David S.","family":"Segal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Kuczenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan L.","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Melega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur K.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,15]]},"reference":[{"key":"2188_CR1","first-page":"387","volume-title":"Amphetamine and its analogues","author":"B Angrist","year":"1994","unstructured":"Angrist B (1994) Amphetamine psychosis: clinical variations of the syndrome. In: Cho AK, Segal DS (eds) Amphetamine and its analogues. Academic, San Diego, pp 387\u2013414"},{"key":"2188_CR2","first-page":"820","volume":"237","author":"JV Barnett","year":"1986","unstructured":"Barnett JV, Kuczenski R (1986) Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration. J Pharmacol Exp Ther 237:820\u2013825","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR3","first-page":"40","volume":"242","author":"JV Barnett","year":"1987","unstructured":"Barnett JV, Segal DS, Kuczenski R (1987) Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization. J Pharmacol Exp Ther 242:40\u201347","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR4","first-page":"845","volume-title":"Handbook of neurotoxicology","author":"JF Bowyer","year":"1995","unstructured":"Bowyer JF, Holson RR (1995) Methamphetamine and amphetamine neurotoxicity. In: Chang LW, Dyer RS (eds) Handbook of neurotoxicology. Marcel Dekker, Inc., New York, pp 845\u2013870"},{"key":"2188_CR5","first-page":"105","volume":"280","author":"WA Cass","year":"1997","unstructured":"Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Pharmacol Exp Ther 280:105\u2013113","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR6","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1523\/JNEUROSCI.19-17-07653.1999","volume":"19","author":"WA Cass","year":"1999","unstructured":"Cass WA, Manning MW (1999) Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J Neurosci 19:7653\u20137660","journal-title":"J Neurosci"},{"key":"2188_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0925-4927(02)00004-5","volume":"114","author":"L Chang","year":"2002","unstructured":"Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN (2002) Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res Neuroimaging 114:65\u201379","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2188_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E","volume":"39","author":"AK Cho","year":"2001","unstructured":"Cho AK, Melega WP, Kuczenski R, Segal DS (2001) Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39:161\u2013166","journal-title":"Synapse"},{"key":"2188_CR9","first-page":"717","volume":"21","author":"CE Cook","year":"1993","unstructured":"Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, Perez-Reyes M (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21:717\u2013723","journal-title":"Drug Metab Dispos"},{"key":"2188_CR10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(95)00614-V","volume":"690","author":"CL Coulter","year":"1995","unstructured":"Coulter CL, Happe HK, Bergman DA, Murrin LC (1995) Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55. Brain Res 690:217\u2013224","journal-title":"Brain Res"},{"key":"2188_CR11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0306-4522(89)90214-5","volume":"33","author":"F Darchen","year":"1989","unstructured":"Darchen F, Masueo Y, Vial M, Rostene W, Scherman D (1989) Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin. Neuroscience 33:341\u2013349","journal-title":"Neuroscience"},{"key":"2188_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00054-6","volume":"36","author":"C Davidson","year":"2001","unstructured":"Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 36:1\u201322","journal-title":"Brain Res Rev"},{"key":"2188_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(92)90201-J","volume":"598","author":"AJ Eisch","year":"1992","unstructured":"Eisch AJ, Gaffney M, Weihmuller FB, O\u2019Dell SJ, Marshall JF (1992) Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res 598:321\u2013326","journal-title":"Brain Res"},{"key":"2188_CR14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.54.6.1344","volume":"54","author":"T Ernst","year":"2000","unstructured":"Ernst T, Chang L, Leonido-Yee M, Speck O (2000) Evidence for long-term neurotoxicity associated with methamphetamine abuse\u2014a 1H MRS study. Neurology 54:1344\u20131349","journal-title":"Neurology"},{"key":"2188_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00639-7","volume":"406","author":"AE Fleckenstein","year":"2000","unstructured":"Fleckenstein AE, Gibb JW, Hanson GR (2000) Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol 406:1\u201313","journal-title":"Eur J Pharmacol"},{"key":"2188_CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0014-2999(97)01152-7","volume":"334","author":"KA Frey","year":"1997","unstructured":"Frey KA, Kilbourn MR, Robinson TE (1997) Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur J Pharmacol 334:273\u2013279","journal-title":"Eur J Pharmacol"},{"key":"2188_CR17","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1523\/JNEUROSCI.23-19-07239.2003","volume":"23","author":"UE Ghitza","year":"2003","unstructured":"Ghitza UE, Fabbricatore AT, Prokopenko V, Pawlak AP, West MO (2003) Persistent cue-evoked activity of accumbens neurons after prolonged abstinence from self-administered cocaine. J Neurosci 23:7239\u20137245","journal-title":"J Neurosci"},{"key":"2188_CR18","first-page":"1042","volume":"292","author":"J Gilles","year":"2000","unstructured":"Gilles J, Rivi\u00e8re GJ, Gentry WB, Owens SM (2000) Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. J Pharmacol Exp Ther 292:1042\u20131047","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0161-813X(01)00046-8","volume":"22","author":"TR Guilarte","year":"2001","unstructured":"Guilarte TR (2001) Is methamphetamine abuse a risk factor in parkinsonism? Neurotoxicology 22:725\u2013731","journal-title":"Neurotoxicology"},{"key":"2188_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0306-4522(03)00476-7","volume":"122","author":"TR Guilarte","year":"2003","unstructured":"Guilarte TR, Nihei MK, McGlothan JL, Howard AS (2003) Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity. Neuroscience 122:499\u2013513","journal-title":"Neuroscience"},{"key":"2188_CR21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0028-3908(96)84647-8","volume":"35","author":"MP Gygi","year":"1996","unstructured":"Gygi MP, Gygi SP, Johnson M, Wilkins DG, Gibb JW, Hanson GR (1996) Mechanisms for tolerance to methamphetamine effects. Neuropharmacology 35:751\u2013757","journal-title":"Neuropharmacology"},{"key":"2188_CR22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clpt.2003.08.002","volume":"74","author":"DS Harris","year":"2003","unstructured":"Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT (2003) The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther 74:475\u2013486","journal-title":"Clin Pharmacol Ther"},{"key":"2188_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-8993(00)02439-2","volume":"871","author":"DC Harvey","year":"2000","unstructured":"Harvey DC, Lacan G, Tanious SP, Melega WP (2000) Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 871:259\u2013270","journal-title":"Brain Res"},{"key":"2188_CR24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1021\/js950493j","volume":"85","author":"A Hutchaleelaha","year":"1996","unstructured":"Hutchaleelaha A, Mayersohn M (1996) Influence of activated charcoal on the disposition kinetics of methamphetamine enantiomers in the rat following intravenous dosing. J Pharm Sci 85:541\u2013545","journal-title":"J Pharm Sci"},{"key":"2188_CR25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2003.09.006","volume":"24","author":"EH Jacobs","year":"2003","unstructured":"Jacobs EH, Smit AB, De Vries TJ, Schoffelmeer ANM (2003) Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol Sci 24:566\u2013573","journal-title":"Trends Pharmacol Sci"},{"key":"2188_CR26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0379-0738(00)00368-6","volume":"116","author":"KS Kalasinsky","year":"2001","unstructured":"Kalasinsky KS, Bosy TZ, Schmunk GA, Reiber G, Anthony RM, Furukawa Y, Guttman M, Kish SJ (2001) Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users. Forensic Sci Int 116:163\u2013169","journal-title":"Forensic Sci Int"},{"key":"2188_CR27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(03)01321-9","volume":"464","author":"K Kitaichi","year":"2003","unstructured":"Kitaichi K, Morishita Y, Doi Y, Ueyama J, Matsushima M, Zhao YL, Takagi K, Hasegawa T (2003) Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats. Eur J Pharmacol 464:39\u201348","journal-title":"Eur J Pharmacol"},{"key":"2188_CR28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","volume":"15","author":"R Kuczenski","year":"1995","unstructured":"Kuczenski R, Segal DS, Cho AK, Melega WP (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308\u20131317","journal-title":"J Neurosci"},{"key":"2188_CR29","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","volume":"18","author":"UD McCann","year":"1998","unstructured":"McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 18:8417\u20138422","journal-title":"J Neurosci"},{"key":"2188_CR30","first-page":"90","volume":"274","author":"WP Melega","year":"1995","unstructured":"Melega WP, Williams AE, Schmitz DA, DiStefano EW, Cho AK (1995) Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274:90\u201396","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(94)90136-8","volume":"173","author":"L Naudon","year":"1994","unstructured":"Naudon L, Leroux-Nicollet I, Costentin J (1994) Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra. Neurosci Lett 173:1\u20134","journal-title":"Neurosci Lett"},{"key":"2188_CR32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00432141","volume":"68","author":"EN Nielsen","year":"1980","unstructured":"Nielsen EN, Lee TH, Ellison G (1980) Following several days of continuous administration d-amphetamine acquires hallucinogen-like properties. Psychopharmacology 68:197\u2013200","journal-title":"Psychopharmacology"},{"key":"2188_CR33","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, Sydney"},{"key":"2188_CR34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-8993(80)90952-X","volume":"193","author":"GA Ricaurte","year":"1980","unstructured":"Ricaurte GA, Schuster CR, Seiden LS (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193:153\u2013163","journal-title":"Brain Res"},{"key":"2188_CR35","first-page":"1220","volume":"291","author":"GJ Rivi\u00e8re","year":"1999","unstructured":"Rivi\u00e8re GJ, Byrnes KA, Gentry WB, Owens SM (1999) Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J Pharmacol Exp Ther 291:1220\u20131226","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR36","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1523\/JNEUROSCI.06-08-02245.1986","volume":"6","author":"JM Roberts-Lewis","year":"1986","unstructured":"Roberts-Lewis JM, Roseboom PH, Iwaniec LM, Gnegy ME (1986) Differential down-regulation of D1-stimulated adenylate cyclase activity in rat forebrain after in vivo amphetamine treatments. J Neurosci 6:2245\u20132251","journal-title":"J Neurosci"},{"key":"2188_CR37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0006-8993(85)90748-6","volume":"343","author":"CJ Schmidt","year":"1985","unstructured":"Schmidt CJ, Gehlert DR, Peat MA, Sonsalla PK, Hanson GR, Wamsley JK, Gibb JW (1985a) Studies on the mechanism of tolerance to methamphetamine. Brain Res 343:305\u2013313","journal-title":"Brain Res"},{"key":"2188_CR38","first-page":"539","volume":"233","author":"CJ Schmidt","year":"1985","unstructured":"Schmidt CJ, Ritter JK, Sonsalla PK, Hanson GR, Gibb JW (1985b) Role of dopamine in the neurotoxic effects of methamphetamine. J Pharmacol Exp Ther 233:539\u2013544","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/bmc.1130040509","volume":"4","author":"D Schmidt","year":"1990","unstructured":"Schmidt D, Roznoski M, Ebert MH (1990) Qualitative and quantitative high performance liquid chromatographic analysis of monoamine neurotransmitters and metabolites in cerebrospinal fluid and brain tissue using reductive electrochemical detection. Biomed Chromatogr 4:215\u2013220","journal-title":"Biomed Chromatogr"},{"key":"2188_CR40","first-page":"247","volume-title":"Advances in biochemical psychopharmacology","author":"DS Segal","year":"1975","unstructured":"Segal DS (1975) Behavioral and neurochemical correlates of repeated d-amphetamine administration. In: Mandell AJ (ed) Advances in biochemical psychopharmacology. Raven Press, New York, pp 247\u2013266"},{"key":"2188_CR41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(74)90395-3","volume":"68","author":"DS Segal","year":"1974","unstructured":"Segal DS, Kuczenski R (1974) Tyrosine hydroxylase activity: regional and subcellular distribution in brain. Brain Res 68:261\u2013266","journal-title":"Brain Res"},{"key":"2188_CR42","first-page":"917","volume":"242","author":"DS Segal","year":"1987","unstructured":"Segal DS, Kuczenski R (1987) Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. J Pharmacol Exp Ther 242:917\u2013926","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR43","first-page":"115","volume-title":"Amphetamine and its analogues: psychopharmacology, toxicology and abuse","author":"DS Segal","year":"1994","unstructured":"Segal DS, Kuczenski R (1994) Behavioral pharmacology of amphetamine. In Cho AK, Segal DS (eds) Amphetamine and its analogues: psychopharmacology, toxicology and abuse. Academic, San Diego, pp 115\u2013150"},{"key":"2188_CR44","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1523\/JNEUROSCI.17-07-02551.1997","volume":"17","author":"DS Segal","year":"1997","unstructured":"Segal DS, Kuczenski R (1997a) An escalating dose \u201cbinge\u201d model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 17:2551\u20132566","journal-title":"J Neurosci"},{"key":"2188_CR45","first-page":"561","volume":"282","author":"DS Segal","year":"1997","unstructured":"Segal DS, Kuczenski R (1997b) Repeated binge exposure to amphetamine and methamphetamine: behavioral and neurochemical characterization. J Pharmacol Exp Ther 282:561\u2013573","journal-title":"J Pharmacol Exp Ther"},{"key":"2188_CR46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s002130050878","volume":"142","author":"DS Segal","year":"1999","unstructured":"Segal DS, Kuczenski R (1999b) Escalating dose\/binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen\/nucleus accumbens dopamine responses. Psychopharmacology 142:182\u2013192","journal-title":"Psychopharmacology"},{"key":"2188_CR47","volume-title":"Contemporary neuropsychiatry (Proceedings of the 3rd International Congress of Neuropsychiatry)","author":"DS Segal","year":"2000","unstructured":"Segal DS, Kuczenski R (2000) Escalating dose-binge exposure to amphetamine and methamphetamine: behavioral and neurochemical characterization. In: Contemporary neuropsychiatry (Proceedings of the 3rd International Congress of Neuropsychiatry). Springer-Verlag, Tokyo"},{"key":"2188_CR48","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/sj.npp.1300247","volume":"28","author":"DS Segal","year":"2003","unstructured":"Segal DS, Kuczenski R, O\u2019Neil ML, Melega WP, Cho AK (2003) Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology 28:1730\u20131740","journal-title":"Neuropsychopharmacology"},{"key":"2188_CR49","first-page":"359","volume-title":"Psychopharmacology: the third generation of progress","author":"LS Seiden","year":"1987","unstructured":"Seiden LS, Ricaurte GA (1987) Neurotoxicity of methamphetamine and related drugs. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 359\u2013366"},{"key":"2188_CR50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-2999(99)00110-7","volume":"370","author":"X Shi","year":"1999","unstructured":"Shi X, Yin R, Dow-Edwards D (1999) Chronic haloperidol alters dopamine receptors: effects of cocaine exposure during the preweaning period. Eur J Pharmacol 370:241\u2013249","journal-title":"Eur J Pharmacol"},{"key":"2188_CR51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J069v21n01_04","volume":"21","author":"SL Simon","year":"2002","unstructured":"Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, Ling W (2002) A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 21:35\u201344","journal-title":"J Addict Dis"},{"key":"2188_CR52","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1176\/appi.ajp.160.5.896","volume":"160","author":"JC Tong","year":"2003","unstructured":"Tong JC, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y, Ang LC, Aiken SS, Wickham DJ, Kish SJ (2003) Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. Am J Psychiatry 160:896\u2013903","journal-title":"Am J Psychiatry"},{"key":"2188_CR53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0006-8993(01)02269-7","volume":"900","author":"EM Unterwald","year":"2001","unstructured":"Unterwald EM, Kreek MJ, Cuntapay M (2001) The frequency of cocaine administration impacts cocaine-induced receptor alterations. Brain Res 900:103\u2013109","journal-title":"Brain Res"},{"key":"2188_CR54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-2999(95)00594-3","volume":"294","author":"TM Vander Borght","year":"1995","unstructured":"Vander Borght TM, Kilbourn MR, Desmond T et al (1995) The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 294:577\u2013583","journal-title":"Eur J Pharmacol"},{"key":"2188_CR55","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001a) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015\u20132021","journal-title":"Am J Psychiatry"},{"key":"2188_CR56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001c) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377\u2013382","journal-title":"Am J Psychiatry"},{"key":"2188_CR57","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1523\/JNEUROSCI.16-10-03507.1996","volume":"16","author":"JM Wilson","year":"1996","unstructured":"Wilson JM, Kish SJ (1996) The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. J Neurosci 16:3507\u20133510","journal-title":"J Neurosci"},{"key":"2188_CR58","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","volume":"2","author":"JM Wilson","year":"1996","unstructured":"Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699\u2013703","journal-title":"Nat Med"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-2188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-2188-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-2188-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:31:14Z","timestamp":1558614674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-2188-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,15]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-2188-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,15]]}}}